NEW YORK (GenomeWeb News) – The Salk Institute for Biological Sciences has launched a campaign to raise $300 million in private funding to support a new genomic medicine initiative, as well as new cancer, aging, and neuroscience programs.

Speaking at a press conference yesterday, Salk's Chair of the Board of Trustees, Irwin Jacobs, said the institute has already raised $150 million from private individuals and foundations during a quiet phase of campaign fundraising that began in 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Sciencethis week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.